This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations that are manufactured using a standard lyophilization process. The small tablets are packaged in unit-dose blisters offering an inexpensive, scalable, and easy-to-use product presentation for live attenuated vaccines containing single or multiple bacterial strains. Further, the stackable product presentation may minimize product volume and thus the space required for storage and transport, resulting in significant savings from a health system and cold chain capacity perspective.

Author(s): PATH

Published: 2012

Resource types: PATH resource; Fact sheet

Diseases: Shigellosis and enterotoxigenic Escherichia coli (ETEC); Rotavirus

Topics: Introduction and service delivery; Cold chain logistics and technologies; Presentation and packaging; Vaccine stabilization

Regions: Global